BioPharma Conference

What happens when your company is acquired by a larger company? And what if it's your partner that gets acquired? The show must go on, and the alliance must continue, but it takes a "maestro" of the art and science of alliance management to navigate through an acquisition and integration. Continue Reading

A recent ASAP BioPharma Conference roundtable found that partners are splitting up sales duty by country, the biopharma partnering ecosystem is getting larger and more complex, internal company transformations are impacting alliances, and not enough attention is being paid to exit strategies. Continue Reading

Few people outside of the technology industry have thought to apply the agile framework to their business. Two Cancer Research UK executives told the story of how the organization used it to revamp how it monitored the overall performance of its clinical trial operation. Continue Reading

Alliances are essential to the success of GE Healthcare's Edison Artificial Intelligence (AI) platform, but it couldn’t simply employ “business as usual” partnering practices. Instead, and ecosystem of partners are creating their own "sandboxes.” Continue Reading

The CEO of a device startup shared his team's surprises and alliance lessons learned in this ASAP BioPharma Conference 2021 day two keynote. Continue Reading

Fundamental partnering practices combined with a modern digital platform will boost value realization, operational efficiency, risk management, and strategic agility across the portfolio, according to allianceboard's Digital Alliance Maturity Index. Continue Reading

In biopharma today, it's all about collaboration and putting the patient at the center. Two CEOs discussed how their partnership thrives on openness, trust, and shared goals and how it continually keeps the focus on patient needs. Continue Reading

The 2021 ASAP BioPharma Conference panel “Partnering for Patient Impact” revealed some ways alliance managers can create a patient-focused culture across their portfolios, measure the impact alliances have on patients, and foster innovations that can directly improve patient experiences. Continue Reading

The collaboration between Halozyme and argenx is a powerful combination. The two companies' CEOs will tell how and why it works and why such partnerships are more important than ever in an increasingly patient-centric pandemic world. Continue Reading

Alliance portfolios are at the center of business models that directly impact innovation. Portal Instruments CEO Patrick Anquetil, will reveal his company’s alliance-centric model is developing needle-free injections at the 2021 ASAP BioPharma Conference. Continue Reading

Everybody is now expected to operate with the patient front and center in their minds—including alliance managers, which is necessitating a shift in how they select partners, devise alliance strategy, and execute collaborations. Continue Reading

Patients and Precision: 2021 ASAP BioPharma Conference Explores Collaboration in the Increasingly Digital World of Healthcare As we emerge from the pandemic, the biopharmaceutical industry is faced with a variety of challenges old and new—and some old ones with a new twist. The industry... Continue Reading